FDA to Hold First Public Meeting on CBD

FDA to Hold First Public Meeting on CBD

Recently, the U.S. Food and Drug Administration held a public meeting to discuss products that have CBD oil in them. CBD is short for cannabidiol and is naturally occurring in marijuana and hemp. The FDA held the meeting because there is currently very little information about the potential harmful effects of CBD use and its consumption. This was the FDA’s first ever meeting about CBD and related products. Some of the items of concern include oils, lotions, pills, and gummies. Some of the dozens of people who were invited included consumers, members of the cannabis business community, and doctors. No specific invitees were mentioned by name. The deputy commissioner of the FDA, Dr. Amy Abernathy, recently tweeted that they’ve been reviewing data and literature about the safety of CBD and have found the existing data to be lacking. Her tweet asked about what might happen when you eat foods with CBD or if you used a skin cream that had CBD. She’s also concerned about the effects of its use short term vs long term. The meeting is mainly focused on information gathering. NBC News also reported that this may also be a first step taken by the FDA to regulate its use, manufacture, and distribution.

Key Points:

  • 1There is a meeting in the works to get info on all of the products with CBD in them.
  • 2Oils, lotion, as well as gummies are some items that contain CBD.
  • 3There will be both doctors and consumers at the upcoming meeting about CBD.